小儿支气管哮喘急性发作期呼吸道感染的观察及治疗研究

Observation and Treatment of Respiratory Tract Infection During Acute Episode of Bronchial Asthma in Children

目的探讨小儿支气管哮喘急性发作期呼吸道感染的治疗效果。方法选择2016年2月—2017年3月80例小儿支气管哮喘急性发作期呼吸道感染患儿分组。对照组进行常规治疗,观察组在对照组基础上给予小青龙口服液。比较两组小儿支气管哮喘急性发作期呼吸道感染控制率;呼吸困难、哮鸣音和咳嗽等症状消失时间;干预前后患儿炎症指标和免疫指标。结果观察组小儿支气管哮喘急性发作期呼吸道感染控制率高于对照组,P<0.05;观察组呼吸困难、哮鸣音和咳嗽等症状消失时间短于对照组,P<0.05;干预前两组炎症指标和免疫指标相近,P>0.05;干预后观察组炎症指标和免疫指标优于对照组,P<0.05。结论小儿支气管哮喘急性发作期呼吸道感染给予常规治疗+小青龙口服液治疗效果肯定,可控制炎症水平,缩短疗程。

Objective To investigate the therapeutic effect of respiratory tract infection in children with acute attack of bronchial asthma. MethodsFrom February 2016 to March 2017, 80 children with acute respiratory tract infection in bronchial asthma were divided into groups. The control group was treated with routine treatment, and the observation group was given xiaoqinglong oral liquid based on the control group. The control rate of respiratory tract infection, disappearance of symptoms such as dyspnea, wheeze and coughing, the inflammation index and immune index of the children before and after intervention between the two groups were compared. Results The control rate of respiratory tract infection in children with bronchial asthma in the observation group was higher than that of the control group, P〈0.05. The symptoms of dyspnea, wheeze and coughing in the observation group were shorter than those in the control group, P〈0.05; Before intervention, the two groups of inflammatory indexes and immune indexes were similar, P〈0.05. The index of inflammation and immune index in the observation group were better than those in the control group, P〈0.05. Conclusion The treatment of respiratory tract infection in acute episode of bronchial asthma in children is given by routine treatment ＋ xiaoqinglong oral liquid, which can control the level of inflammation and shorten the course of treatment.